Over the course of the projected period, sales of antisense oligonucleotide market are expected to expand at a Compound Annual Growth Rate (CAGR) of 6.6%, reflecting the market’s enormous potential. By 2033, it is expected to bring in approximately US$ 5,519.6 million, a significant rise from US$ 2,913.5 million in 2023. Unveiling therapeutic potential, the …